Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03176472 Completed - Clinical trials for Painful Diabetic Peripheral Neuropathy

Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

Start date: December 7, 2020
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, 2-arm, parallel group study of up to 274 evaluable patients designed to evaluate the safety and efficacy of the histone deacetylase 6 (HDAC6) inhibitor ricolinostat for painful DPN.

NCT ID: NCT03176381 Completed - Clinical trials for Metastatic Castration-resistant Prostate Cancer

Tissue Predictors of Abiraterone Benefit

Start date: May 5, 2017
Phase:
Study type: Observational

This is an observational, prospective (study following participants forward in time), multi-center (study conducted in more than 1 center) study to identify the predictive factors that will effectively predict the response to abiraterone treatment in metastatic castration-resistant prostate cancer (mCRPC). The entire duration of study will be approximately 3 year. Participants will primarily be evaluated for achieving biochemical or radiological progression after receiving abiraterone treatment based on EAU 2017 practice guideline criteria. For this, we put our attentions on the HOXB3 (an alternative factor of WNT signaling pathway), FKBP5 (FK506 Binding Protein 5, Androgen-regulated gene), NTS (neurotensin, neuroendocrine differentiation can be induced by NTS) and YAP1 (yes-associated protein 1, a biomarker for cancer stem cell), which are selected from the data of gene-array for various subtypes of CRPC (unpublished data). Response to abiraterone treatment will also be predicted using other androgen-regulated genes like AKR1C3 and PCNA.

NCT ID: NCT03176134 Completed - Clinical trials for Acute Bacterial Skin and Skin Structure Infections

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Start date: January 20, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety, tolerability, and efficacy of tedizolid phosphate (MK-1986) compared with comparator antibacterial agent in participants from birth to less than 12 years of age with acute bacterial skin and skin structure infections (ABSSSI).

NCT ID: NCT03175575 Completed - Clinical trials for Nutritional Quality of Food Purchases

Pilot Study on Community Gardens and Food Purchases in Deprived Neighborhood (Marseille, France)

Start date: May 1, 2014
Phase:
Study type: Observational

The pilot study aims to investigate the place of fresh garden produce in the food supply and food practices of women in community gardens of deprived neighborhoods of Marseille, reputed to be among the poorest in the European Union. We hypothesized that access to a community garden in these neighborhoods could help instigate the adoption of healthier food patterns by gardeners and their households, and in particular, increase their consumption of fruits and vegetables.

NCT ID: NCT03175406 Completed - Clinical trials for Induction of Labor Affected Fetus / Newborn

Predicting the Outcomes of Labor Induction

Start date: April 1, 2016
Phase: N/A
Study type: Observational

Pre induction assessment using bishop scoring system and Manipal cervical scoring system performed on 105 pregnant females

NCT ID: NCT03174847 Completed - Clinical trials for Primary Aldosteronism

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

PA_PACES
Start date: February 20, 2017
Phase:
Study type: Observational

Majority of patients with hypertension have primary hypertension (without an underlying cause). Secondary hypertension (due to an underlying disease) is important to recognize, as treatment can lead to cure of hypertension. Primary aldosteronism (PA) is the most common cause of secondary hypertension, and can be found in 5-10% of patients locally. PA is caused by excessive release of a hormone (aldosterone) from the adrenal glands, which can be unilateral (one gland) or bilateral (both glands). Distinction between two is crucial as unilateral disease is treated with the aim of cure by surgery, and bilateral disease is treated by medication. It has been shown that excess aldosterone has other harmful effects in addition to hypertension, such as directly affecting the heart, blood vessels, kidneys, diabetes and quality of life. This is supported by studies showing reversal of these effects after treatment for PA. In addition, improvements after surgery appears to be superior to medical treatment, although studies have found variable results. Hence, the investigators aim to accurately subtype patients with PA into unilateral or bilateral disease and study the post-treatment response after both surgery and medicine with regards to the effects on blood pressure, cardiovascular, renal, metabolic and quality of life.

NCT ID: NCT03174821 Completed - Clinical trials for Insulin Pump Therapy in Treating Diabetic Nephropathy

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Start date: October 20, 2010
Phase: N/A
Study type: Interventional

The recent study suggested that oxidative stress resulting from increased production of reactive oxygen species (ROS) plays a crucial role in the development of diabetic complications. The researches aim to monitor the level of oxidative stress of patient in different stage of diabetic nephropathy before and after insulin pump therapy.

NCT ID: NCT03173495 Completed - Dyslipidemias Clinical Trials

Effects of Exercise on Fructose-induced Postprandial Lipemia

Start date: January 10, 2016
Phase: N/A
Study type: Interventional

Cardiovascular Diseases (CVDs) are the leading causes of death in the world and in Brazil. In 2001, 12.45 million deaths on the globe (21% of the total) were caused by some CVD. The composition of modern man's diet has changed drastically with the industrialization of food, resulting in the transition from a diet rich in fibers and complex carbohydrates to one with a high content of sugars and fats. Since the current dietary pattern is characterized by the consumption of three or more meals a day, containing a quantity of fat in the range of 20 to 70 g, individuals spend a large part of the day in the postprandial state, with continuous fluctuation of lipemia Over 18 hours. Food intake (postprandial state) is the dynamic, unstable response of the body that refers to rapid hormonal and lipoprotein remodeling. It is well established in the literature that high-fat meals (lipid overload) cause an increase in plasma triglycerides. Hypertriglyceridemia and / or elevated triglyceride-rich lipoproteins (LRT) (chylomicrons, VLDL and their remnants) in the postprandial state induces endothelial dysfunction via increased oxidative stress and is an independent risk factor for CVDs. Therefore, Postprandial Lipemia (PPL) is counted as an early marker of atherosclerotic process, metabolic abnormalities and endothelial dysfunction. High-carbohydrate (CHO) diets may promote increased LDL-c, TG, VLDL and HDL-c reduction, as well as PPL, generating a lipid profile associated with an increased risk of CVDs. This effect appears to be more pronounced with the inclusion of simple carbohydrates (mono and disaccharides), although it also occurs with diets rich in complex carbohydrates (polysaccharides). High fructose diets (HFDs) are a known model of induction of insulin resistance, dyslipidemia and DM2 in primates and humans. The chronic effect of fructose consumption has been well studied in the last decades due to its connection with obesity, resistance to Insulin, accumulation of visceral fat and dyslipidemia. As the consumption of fructose is progressively increasing in society and its chronic exposure can generate a phenotypic effect of dyslipidemia and, consequently, the increased risk of CVDs, prevention and treatment strategies should be seen as an important public health issue . Thus, the objective of this study is to understand the effects of exercise on fat metabolism, since there is a lack of robust evidence about the possible cardioprotective and hypolipemic role of the same on HFD.

NCT ID: NCT03173079 Completed - Clinical trials for Possible Change in Geriatric Assessment After TAVI

Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement

Start date: March 15, 2017
Phase:
Study type: Observational

A geriatric assessment is becoming increasingly important in the treatment of patients with a percutaneous aortic valve replacement due to their comorbidities. The aim of this multimodal therapy concept is to examine the influence on the postoperative outcome. In addition to a comprehensive assessment of the individual frailty score, the subjective condition before and after TAVI is also evaluated using a standardized questionnaire ("Minnesota living with heart failure questionnaire").

NCT ID: NCT03172884 Completed - Clinical trials for Hepatic Insufficiency, Renal Insufficiency

Study of Copanlisib in Hepatic or Renal Impairment

Start date: June 14, 2017
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects